Advertisement

Estrogens and Other Hormones in the Treatment of Premenstrual Syndromes

  • Leslie Born
  • Meir Steiner

Keywords

GnRH Agonist Premenstrual Syndrome Premenstrual Symptom Premenstrual Dysphoric Disorder Pregnenolone Sulfate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. American Psychiatric Association (1994) Premenstrual dysphoric disorder. In: Diagnostic and statistical manual of mental disorders, 4th ed. American Psychiatric Association, Washington DC, 715–718Google Scholar
  2. Bäckström T, Hansson-Malmström Y, Lindhe B-Å, Cavalli-Björkman B, Nordenström S (1992) Oral contraceptives in premenstrual syndrome: a randomized comparison of triphasic and monophasic preparations. Contraception 46: 253–268PubMedGoogle Scholar
  3. Bancroft J, Rennie D (1993) The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms. J Psychosom Res 37: 195–202PubMedCrossRefGoogle Scholar
  4. Bancroft J, Sanders D, Warner P, Loudon N (1987) The effects of oral contraceptives on mood and sexuality: a comparison of triphasic and combined preparations. J Psychosom Obstet Gynaecol 7: 1–8Google Scholar
  5. Bicikova M, Dibbelt L, Hill M, Hampl R, Starka L (1998) Allopregnanolone in women with premenstrual syndrome. Horm Metab Res 30: 227–30PubMedGoogle Scholar
  6. Born L, Steiner M (2001) Current management of premenstrual syndrome and premenstrual dysphoric disorder. Curr Psychiatr Reports 3: 463–469Google Scholar
  7. Brown CS, Ling FW, Andersen RN, Farmer RG, Arheart KL (1994) Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial. Obstet Gynecol 84: 779–786PubMedGoogle Scholar
  8. Burnet RB, Radden HS, Easterbrook EG, McKinnon RA (1991) Premenstrual syndrome and spironolactone. Aust N Z J Obstet Gynaecol 31: 366–368PubMedGoogle Scholar
  9. Casper RF, Hearn MT (1990) The effect of hysterectomy and bilateral oophorectomy in women with severe premenstrual syndrome. Am J Obstet Gynecol 162: 105–109PubMedGoogle Scholar
  10. Casson P, Hahn PM, Van Vugt DA, Reid RL (1990) Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am J Obstet Gynecol 162: 99–105PubMedGoogle Scholar
  11. Chan AF, Mortola JF, Wood SH, Yen SS (1994) Persistence of premenstrual syndrome during low-dose administration of the progesterone antagonist RU 486. Obstet Gynecol 84: 1001–1005PubMedGoogle Scholar
  12. Crammer JL (1986) Premenstrual depression, cortisol and oestradiol treatment. Psychol Med 16: 451–455PubMedCrossRefGoogle Scholar
  13. Dalton K (1990) The aetiology of premenstrual syndrome is with the progesterone receptors. Med Hypotheses 31: 323–327PubMedCrossRefGoogle Scholar
  14. Dennerstein L, Morse C, Gotts G, Brown J, Smith M, Oats J, Burrows G (1986) Treatment of premenstrual syndrome a double-blind trial of dydrogesterone. J Affect Disord 11: 199–205PubMedCrossRefGoogle Scholar
  15. Dennerstein L, Spencer-Gardner C, Gotts G, Brown JB, Smith MA, Burrows GD (1985) Progesterone and the premenstrual syndrome: a double blind crossover trial. Br Med J 290: 1617–1621Google Scholar
  16. Dhar V, Murphy BE (1990) Double-blind randomized crossover trial of luteal phase estrogens (Premarin) in the premenstrual syndrome (PMS). Psychoneuroen-docrinology 15: 489–493Google Scholar
  17. Dhar V, Murphy BE (1991) The premenstrual syndrome and its treatment. J Steroid Biochem Mol Biol 9: 275–281Google Scholar
  18. Di Carlo C, Palomba S, Tommaselli GA, Guida M, Di Spiezio Sardo A, Nappi C (2001) Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome. Fertil Steril 75: 380–384PubMedGoogle Scholar
  19. Dimmock PW, Wyatt KM, Jones PW, O'Brien PMS (2000) Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 356: 1131–1136PubMedCrossRefGoogle Scholar
  20. Endicott J, Amsterdam J, Eriksson E, Frank E, Freeman E, Hirschfeld R, Ling F, Parry B, Pearlstein T, Rosenbaum J, Rubinow D, Schmidt P, Severino S, Steiner M, Stewart DE, Thys-Jacobs S (1999) Is premenstrual dysphoric disorder a distinct clinical entity? J Womens Health Gender-based Med 8: 663–679Google Scholar
  21. Epperson CN, Haga K, Mason GF, Sellers E, Gueorguieva R, Zhang W, Weiss E, Rothman DL, Krystal JH (2002) Cortical γ-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder. Arch Gen Psychiatry 59: 851–858PubMedGoogle Scholar
  22. Epperson CN, Wisner KL, Yamamoto B (1999) Gonadal steroids in the treatment of mood disorders. Psychosom Med 61: 676–697PubMedGoogle Scholar
  23. Eriksson E, Endicott J, Andersch B, Angst J, Demyttenaere K, Facchinetti F, Lanczik M, Montgomery S, Muscettola G, O'Brien PMS, Studd J, Sundblad C, Young AH (2002) New perspectives on the treatment of premenstrual syndrome and premenstrual dysphoric disorder. Arch Women Ment Health 4: 111–119Google Scholar
  24. Eriksson E, Sundblad C, Landén M, Steiner M (2000b) Behavioural effects of androgens in women. In: Steiner M, Yonkers KA, Eriksson E (eds) Mood disorders in women. Martin Dunitz, London, 233–245Google Scholar
  25. Eriksson E, Sundblad C, Yonkers KA, Steiner M (2000a) Premenstrual dysphoria and related conditions: symptoms, pathophysiology and treatment. In: Steiner M, Yonkers KA, Eriksson E (eds) Mood disorders in women. Martin Dunitz, London, 269–293Google Scholar
  26. Frank R (1931) The hormonal causes of premenstrual tension. Arch Neurol Psychiatry 26: 1053–1057Google Scholar
  27. Freeman EW, Frye CA, Rickels K, Martin PA, Smith SS (2002) Allopregnanolone levels and symptom improvement in severe premenstrual syndrome. J Clin Psychopharmacol 22: 516–520PubMedCrossRefGoogle Scholar
  28. Freeman EW, Kroll R, Rapkin A, Pearlstein T, Brown C, Parsey K, Zhang P, Patel H, Foegh M, for the PMS/PMDD Research group (2001b) Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J Womens Health Gender-based Med 10: 561–569Google Scholar
  29. Freeman EW, Purdy RH, Coutifaris C, Rickels K, Paul SM (1993) Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers. Neuroendocrinology 58: 478–484PubMedGoogle Scholar
  30. Freeman EW, Rickels K, Sondheimer SJ, Polansky M (2001a) Concurrent use of oral contraceptives with antidepressants for premenstrual syndromes. J Clin Psychopharmacol 21: 540–542PubMedCrossRefGoogle Scholar
  31. Freeman EW, Rickels K, Sondheimer SJ, Polansky M (1995) A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. J Am Med Assoc 274: 51–57CrossRefGoogle Scholar
  32. Girdler SS, Straneva PA, Light KC, Pedersen CA, Morrow AL (2001) Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 49: 788–797PubMedCrossRefGoogle Scholar
  33. Halbreich U, Kahn LS (2001) Role of estrogen in the aetiology and treatment of mood disorders. CNS Drugs 15: 797–817PubMedGoogle Scholar
  34. Halbreich U, Kahn LS (2000) Selective oestrogen receptor modulators-current and future brain and behaviour applications. Exp Opin Pharmacother 1: 1385–1398Google Scholar
  35. Hammarbäck S, Bäckström T, Holst J, von Schoultz B, Lyrenas S (1985) Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy. Acta Obstet Gynecol Scand 64: 393–397PubMedCrossRefGoogle Scholar
  36. Hammarbäck S, Ekholm UB, Bäckström T (1991) Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome. Acta Endocrin (Cophenh) 125: 132–137Google Scholar
  37. Henshaw C, Foreman D, Belcher J, Cox J, O'Brien S (1996) Can one induce premenstrual symptomatology in women with prior hysterectomy and bilateral oophorectomy? J Psychosom Obstet Gynecol 17: 21–28Google Scholar
  38. Ho HP, Olsson M, Westberg L, Melke J, Eriksson E (2001) The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: an animal model of premenstrual irritability? Neuropsychopharmacology 24: 502–510PubMedCrossRefGoogle Scholar
  39. Kendler KS, Karkowski LM, Corey LA, Neale MC (1998) Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. Am J Psychiatry 155: 1234–1240PubMedGoogle Scholar
  40. Lyall H, Campbell-Brown M, Walker JJ (1999) GnRH analogue in everyday gynecology: is it possible to rationalize its use? Acta Obstet Gynecol Scand 78: 340–345PubMedCrossRefGoogle Scholar
  41. Magos AL, Brincat M, Studd JW (1986) Treatment of the premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone: placebo controlled study. Br Med J 292: 1629–1633CrossRefGoogle Scholar
  42. Majewska MD (1992) Neurosteroids: endogenous bimodal modulators of the GABA receptor Mechanism of action and physiological significance. Progr Neurobiol 38: 379–395PubMedCrossRefGoogle Scholar
  43. Marriott A, Faragher EB (1986) An assessment of psychological state associated with the menstrual cycle in users of oral contraception. J Psychosom Res 30: 41–47PubMedCrossRefGoogle Scholar
  44. Mezrow G, Shoupe D, Spicer D, Lobo R, Leung B, Pike M (1994) Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome. Fertil Steril 62: 932–937PubMedGoogle Scholar
  45. Mitwally MFM, Gotlieb L, Casper RF (2002) Prevention of bone loss and hypoes-trogenic symptoms by estrogen and interrupted progestogen add-back in longterm GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome. Menopause 9: 236–241PubMedGoogle Scholar
  46. Monteleone P, Luisi S, Tonetti A, Bernardi F, Genazzani AD, Luisi M, Petraglia F, Genazzani AR (2000) Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrin 142: 269–73.CrossRefGoogle Scholar
  47. Muse KN, Cetel NS, Futterman LA, Yen SC (1984) The premenstrual syndrome: effects of medical "ovariectomy". N Engl J Med 311: 1345–1349PubMedCrossRefGoogle Scholar
  48. O'Brien PM, Craven D, Selby C, Symonds EM (1979) Treatment of premenstrual syndrome by spironolactone. Br J Obstet Gynaecol 86: 142–147PubMedGoogle Scholar
  49. O'Brien PMS, Abukhalil IEH, Henshaw C (1995) Premenstrual syndrome. Curr Obstet Gynaecol 5: 30–35Google Scholar
  50. O'Brien PMS, Abukhalil IEH (1999) Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol. Am J Obstet Gynecol 180: 18–23PubMedGoogle Scholar
  51. Taskin O, Gokdeniz R, Yalcinoglu A, Buhur A, Burak F, Atmaca R, Ozekici U (1998) Placebo-controlled cross-over study of effects of tibolone on premenstrual symptoms and peripheral beta-endorphin concentrations in premenstrual syndrome. Hum Reprod 13: 2402–2405PubMedGoogle Scholar
  52. Rapkin AJ, Morgan M, Goldman L, Brann DW, Simone D, Mahesh VB (1997) Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 90: 709–714PubMedCrossRefGoogle Scholar
  53. Roca CA, Schmidt PJ, Block M, Rubinow DR (1996) Implications of endocrine studies of premenstrual syndrome. Psychiatr Annuals 26: 576–580Google Scholar
  54. Roy-Byrne P, Rubinow DR, Gold PW, Post RM (1984) Possible antidepressant effect of oral contraceptives: case report. J Clin Psychiatry 45: 350–352PubMedGoogle Scholar
  55. Rubinow DR, Hoban MC, Grover GN, Galloway DS, Roy-Byrne P, Anderson R, Merriam GR (1988) Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am J Obstet Gynecol 158: 5–11PubMedGoogle Scholar
  56. Rubinow DR, Schmidt PJ, Roca CA (1998) Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry 44: 839–850.PubMedCrossRefGoogle Scholar
  57. Sarno AP Jr, Miller EJ Jr, Lundblad EG (1987) Premenstrual syndrome: beneficial effects of periodic, low-dose danazol. Obstet Gynecol 70: 33–36PubMedGoogle Scholar
  58. Schaller JL, Briggs B, Briggs M (2000) Progesterone organogel for premenstrual dysphoric disorder. J Am Acad Child Adolesc Psychiatry 39: 546–547PubMedGoogle Scholar
  59. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR (1998) Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 338: 209–216PubMedCrossRefGoogle Scholar
  60. Schmidt PJ, Nieman LK, Grover GN, Muller KL, Merriam GR, Rubinow DR (1991) Lack of effect of induced menses on symptoms in women with premenstrual syndrome. N Engl J Med 324: 1174–1179PubMedGoogle Scholar
  61. Schmidt PJ, Purdy RH, Moore RH Jr, Paul SM, Rubinow DR (1994) Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrin Metab 79: 1256–1260Google Scholar
  62. Scott RT Jr, Ross B, Anderson C, Archer DF (1991) Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol. Obstet Gynecol 77: 758–764PubMedGoogle Scholar
  63. Smith RN, Studd JW, Zamblera D, Nigel Holland EF (1995) A randomized comparison over 8 months of 100µg and 200µg twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome. Br J Obstet Gynaecol 102: 475–484PubMedGoogle Scholar
  64. Steiner M, Coote M, Wilkins A, Dunn E (1997) Biological correlates of irritability in women with premenstrual dysphoria. Eur Neuropsychopharmacol 7(Suppl 2): S172Google Scholar
  65. Steiner M, Dunn E, Born L (2002) Female-specific mood disorders. In: D'haenen H, den Boer JA, Willner P (eds) Biological psychiatry. Wiley, London, 849–859Google Scholar
  66. Steiner M, Haskett RF, Carroll BJ (1980) Premenstrual tension syndrome: The development of research diagnostic criteria and new rating scales. Acta Psychiatr Scand 62: 177–190PubMedGoogle Scholar
  67. Sundstrom Poromaa I, Smith S, Gulinello M (2003) GABA receptors, progesterone and premenstrual dysphoric disorder. Arch Women Ment Health 6: 23–41PubMedGoogle Scholar
  68. Sveindóttir H, Bäckström T (2000) Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives. Acta Obstet Gynecol Scand 79: 405–413PubMedGoogle Scholar
  69. Walker A, Bancroft J (1990) Relationship between premenstrual symptoms and oral contraceptive use: a controlled study. Psychosom Med 52: 86–96PubMedGoogle Scholar
  70. Wang M, Hammarbäck S, Lindhe B-Å, Bäckström T (1995) Treatment of premenstrual syndrome by spironolactone: A double-blind placebo-controlled study. Acta Obstet Gynecol Scand 74: 803–808PubMedGoogle Scholar
  71. Wang M, Seippel L, Purdy RH, Backstrom T (1996) Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3, 20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J Clin Endocrin Metab 81: 1076–1082Google Scholar
  72. Watson NR, Studd JW, Savvas M, Garnett T, Baber RJ (1989) Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet 2: 730–732PubMedGoogle Scholar
  73. West CP (1990) Inhibition of ovulation with oralprogestins-effectiveness in premenstrual syndrome. Eur J Obstet Gynecol Reproduct Biol 34: 119–128Google Scholar
  74. Willimann H, Walde P, Luisi PL, Gazzaniga A, Stroppolo F (1992) Lecithin organogel as matrix for transdermal transport of drugs. J Pharm Sci 81: 871–874PubMedGoogle Scholar
  75. World Health Organization. International statistical classification of diseases and related problems, vol 10(ICD-10) (1992) World Health Organization Press, GenevaGoogle Scholar
  76. Wyatt K, Dimmock P, Jones P, Obhrai M, O'Brien S (2001) Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review. Br Med J 323: 776–780Google Scholar
  77. Ylostalo P, Kauppila A, Puolakka J, Ronnberg L, Janne O (1982) Bromocriptine and norethisterone in the treatment of premenstrual syndrome. Obstet Gynecol 59: 292–298PubMedGoogle Scholar
  78. Yonkers KA, Bradshaw KD, Halbreich U (2000) Oestrogens, progestins and mood. In: Steiner M, Yonkers KA, Eriksson E (eds) Mood disorders in women. Martin Dunitz, London, 207–232Google Scholar

Copyright information

© Springer-Verlag/Wien 2005

Authors and Affiliations

  • Leslie Born
  • Meir Steiner

There are no affiliations available

Personalised recommendations